These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16554456)

  • 1. Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial.
    Kotzailias N; Andonovski T; Dukic A; Serebruany VL; Jilma B
    J Clin Pharmacol; 2006 Apr; 46(4):468-75. PubMed ID: 16554456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine decreases platelet serotonin storage and platelet function in human beings.
    Hergovich N; Aigner M; Eichler HG; Entlicher J; Drucker C; Jilma B
    Clin Pharmacol Ther; 2000 Oct; 68(4):435-42. PubMed ID: 11061584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
    Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
    Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early effects of paroxetine on serotonin storage, plasma levels, and urinary excretion: a randomized, double-blind, placebo-controlled trial.
    Kotzailias N; Marker M; Jilma B
    J Clin Psychopharmacol; 2004 Oct; 24(5):536-9. PubMed ID: 15349011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin.
    Serebruany VL; Glassman AH; Malinin AI; Atar D; Sane DC; Oshrine BR; Ferguson JJ; O'Connor CM
    Eur J Heart Fail; 2003 Aug; 5(4):517-21. PubMed ID: 12921813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
    Serebruany VL; Gurbel PA; O'Connor CM
    Pharmacol Res; 2001 May; 43(5):453-62. PubMed ID: 11394937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin.
    Reiter RA; Mayr F; Blazicek H; Galehr E; Jilma-Stohlawetz P; Domanovits H; Jilma B
    Blood; 2003 Dec; 102(13):4594-9. PubMed ID: 12920042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism.
    Abdelmalik N; Ruhé HG; Barwari K; van den Dool EJ; Meijers JC; Middeldorp S; Büller HR; Schene AH; Kamphuisen PW
    J Thromb Haemost; 2008 Dec; 6(12):2168-74. PubMed ID: 18983505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.
    Musselman DL; Marzec UM; Manatunga A; Penna S; Reemsnyder A; Knight BT; Baron A; Hanson SR; Nemeroff CB
    Arch Gen Psychiatry; 2000 Sep; 57(9):875-82. PubMed ID: 10986551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial.
    Gardner CD; Zehnder JL; Rigby AJ; Nicholus JR; Farquhar JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):787-93. PubMed ID: 17982321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation.
    Berger JS; Becker RC; Kuhn C; Helms MJ; Ortel TL; Williams R
    Thromb Haemost; 2013 Jan; 109(1):85-92. PubMed ID: 23223800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
    J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels.
    Parker WAE; Schulte C; Barwari T; Phoenix F; Pearson SM; Mayr M; Grant PJ; Storey RF; Ajjan RA
    Cardiovasc Diabetol; 2020 Jan; 19(1):3. PubMed ID: 31910903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial.
    Gouya G; Jilma B; Niel M; Eichelberger B; Wolzt M; Panzer S
    Platelets; 2009 May; 20(3):171-6. PubMed ID: 19437334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
    Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
    Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.